𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A Phase II Trial of Daily Perillyl Alcohol in Patients with Advanced Ovarian Cancer: Eastern Cooperative Oncology Group Study E2E96

✍ Scribed by Howard H. Bailey; Donna Levy; Linda S. Harris; Julian C. Schink; Francine Foss; Peter Beatty; Scott Wadler


Book ID
112248919
Publisher
Elsevier Science
Year
2002
Tongue
English
Weight
39 KB
Volume
85
Category
Article
ISSN
0090-8258

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Phase II trial of gemcitabine in patient
✍ Scott Okuno; Louise M. Ryan; John H. Edmonson; Dennis A. Priebat; Ronald H. Blum πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 75 KB πŸ‘ 2 views

## Abstract ## BACKGROUND The current study was conducted to evaluate the antitumor activity and toxicity of gemcitabine in patients with advanced sarcoma. ## METHODS Twenty‐five patients with advanced sarcomas, who previously were untreated for metastatic disease, were treated on an Eastern Coo

Phase II trial of trimetrexate for patie
✍ Ramesh K. Ramanathan; Stuart Lipsitz; Robert F. Asbury; Raman Qazi; Bernard R. G πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 65 KB πŸ‘ 2 views

## BACKGROUND. A Phase II study was conducted to evaluate the response, duration of response, and duration of survival of patients with measurable gastric carcinoma treated with trimetrexate (TMTX) who had not had prior chemotherapy. ## METHODS. Thirty-three patients with unresectable or metast

Phase 2 trial of pemetrexed disodium and
✍ Robert Dreicer; Hailun Li; Matthew M. Cooney; George Wilding; Bruce J. Roth πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 83 KB πŸ‘ 2 views

## Abstract ## BACKGROUND. There is a need to identify active new regimens in patients with advanced urothelial cancer. Pemetrexed and gemcitabine are active agents in advanced urothelial cancer. A phase 2 trial of the combination of these 2 agents was performed in patients with advanced urothelia